MAPT and Alzheimer disease: Curcumin appears to be a promiscuous AD-drug as it has also been shown to block Aβ toxicity in vivo through inhibition of Tau phosphorylation [11], [17], as well as regulating AβPP and BACE-1 transcription by interfering with copper ions [18] in cell cultures.